BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7488332)

  • 1. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity.
    Tyagi SC; Meyer L; Schmaltz RA; Reddy HK; Voelker DJ
    Atherosclerosis; 1995 Jul; 116(1):43-57. PubMed ID: 7488332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions.
    Tyagi SC; Meyer L; Kumar S; Schmaltz RA; Reddy HK; Voelker DJ
    Can J Cardiol; 1996 Apr; 12(4):353-62. PubMed ID: 8608454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of 92-kDa gelatinase in primary atherosclerotic versus restenotic coronary lesions.
    Brown DL; Hibbs MS; Kearney M; Isner JM
    Am J Cardiol; 1997 Apr; 79(7):878-82. PubMed ID: 9104898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
    Tyagi SC; Kumar S; Cassatt S; Parker JL
    Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries.
    Riessen R; Isner JM; Blessing E; Loushin C; Nikol S; Wight TN
    Am J Pathol; 1994 May; 144(5):962-74. PubMed ID: 8178945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy.
    Nikkari ST; Geary RL; Hatsukami T; Ferguson M; Forough R; Alpers CE; Clowes AW
    Am J Pathol; 1996 Mar; 148(3):777-83. PubMed ID: 8774133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
    Galis ZS; Sukhova GK; Lark MW; Libby P
    J Clin Invest; 1994 Dec; 94(6):2493-503. PubMed ID: 7989608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen content is significantly lower in restenotic versus nonrestenotic vessels after balloon angioplasty in the atherosclerotic rabbit model.
    Coats WD; Whittaker P; Cheung DT; Currier JW; Han B; Faxon DP
    Circulation; 1997 Mar; 95(5):1293-300. PubMed ID: 9054862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix collagen synthesis and degradation following coronary balloon angioplasty.
    Guarda E; Katwa LC; Campbell SE; Tanner MA; Webel RM; Laughlin H; Jenkins S; Myers PR
    J Mol Cell Cardiol; 1996 Apr; 28(4):699-706. PubMed ID: 8732498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural characteristics of human atherectomy tissue from coronary and lower extremity arterial stenoses.
    Bauriedel G; Kandolf R; Schluckebier S; Welsch U
    Am J Cardiol; 1996 Mar; 77(7):468-74. PubMed ID: 8629586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: clinical significance of early tenascin-C expression.
    Imanaka-Yoshida K; Matsuura R; Isaka N; Nakano T; Sakakura T; Yoshida T
    Virchows Arch; 2001 Aug; 439(2):185-90. PubMed ID: 11561759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions.
    Galis ZS; Muszynski M; Sukhova GK; Simon-Morrissey E; Libby P
    Ann N Y Acad Sci; 1995 Jan; 748():501-7. PubMed ID: 7695193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restenosis after directional coronary atherectomy: differences between primary atheromatous and restenosis lesions and influence of subintimal tissue resection.
    Garratt KN; Holmes DR; Bell MR; Bresnahan JF; Kaufmann UP; Vlietstra RE; Edwards WD
    J Am Coll Cardiol; 1990 Dec; 16(7):1665-71. PubMed ID: 2254551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries.
    Wight TN; Lara S; Riessen R; Le Baron R; Isner J
    Am J Pathol; 1997 Oct; 151(4):963-73. PubMed ID: 9327730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions.
    MacLeod DC; Strauss BH; de Jong M; Escaned J; Umans VA; van Suylen RJ; Verkerk A; de Feyter PJ; Serruys PW
    J Am Coll Cardiol; 1994 Jan; 23(1):59-65. PubMed ID: 8277096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions.
    O'Brien ER; Bennett KL; Garvin MR; Zderic TW; Hinohara T; Simpson JB; Kimura T; Nobuyoshi M; Mizgala H; Purchio A; Schwartz SM
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):576-84. PubMed ID: 8624780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries.
    Riessen R; Wight TN; Pastore C; Henley C; Isner JM
    Circulation; 1996 Mar; 93(6):1141-7. PubMed ID: 8653834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy.
    O'Brien ER; Alpers CE; Stewart DK; Ferguson M; Tran N; Gordon D; Benditt EP; Hinohara T; Simpson JB; Schwartz SM
    Circ Res; 1993 Aug; 73(2):223-31. PubMed ID: 8101140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: analysis of tissue obtained from 73 patients by directional atherectomy.
    Garratt KN; Edwards WD; Kaufmann UP; Vlietstra RE; Holmes DR
    J Am Coll Cardiol; 1991 Feb; 17(2):442-8. PubMed ID: 1991902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directional atherectomy versus balloon angioplasty for coronary ostial and nonostial left anterior descending coronary artery lesions: results from a randomized multicenter trial. The CAVEAT-I investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial.
    Boehrer JD; Ellis SG; Pieper K; Holmes DR; Keeler GP; Debowey D; Chapekis AT; Leya F; Mooney MR; Gottlieb RS
    J Am Coll Cardiol; 1995 May; 25(6):1380-6. PubMed ID: 7722137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.